Free shipping on orders over $150

G1 Peptides

COMPARISON TOOL

Compare peptides

Half-life, dosing, mechanism, status — side by side. Select up to four compounds, or start from a preset.

Orforglipron
Max 4 peptides
PropertyOrforglipron
CategoryGLP-1
TypeSmall molecule
MechanismOral non-peptide GLP-1 receptor agonist
StatusPhase 3
Dosing range3–36 mg daily
FrequencyOnce daily (oral)
Half-life~29–49 hours
RouteOral tablet
Onset2–4 weeks for appetite reduction
Studied for
  • Weight management
  • Type 2 diabetes
  • No injections
Key risks
  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
StorageRoom temperature
Available at G1Not currently carried. Ask a provider
ToolsDosage calculator →

PROPERTY COMPARISON · RADAR

Profile shape

DurationQuick OnsetVersatilityTolerabilityUse CasesStackability
Editorial profile scores (0–10) for orientation — not clinical measurements.

TYPICAL DOSE RANGES

Dose envelope

Orforglipron3 mg – 36 mg

Typical per-dose range on a logarithmic scale. Your provider sets your dose.

For educational purposes only. Consult a licensed provider before starting any peptide protocol.